Skip to main content
. 2025 Jan 24;15:1534196. doi: 10.3389/fonc.2025.1534196

Table 1.

Baseline table.

Characteristics Overall (N=180)
group (%)
 ESE 105(58.3%)
 MSR-ESE 75(41.7%)
outcome (disease cure, %) 180(100.0%)
sex(%)
 Female 129(71.7%)
 Male 51(28.3%)
age(%)
 <60 118(65.6%)
 ≥60 62(34.4%)
BMI, kg/m2 23.23 ± 3.03
hypertension or diabetes(%) 69(38.3%)
WBC 5.95 ± 2.05
Hb(g/L) 131.76 ± 14.69
PLT 206.16 ± 47.45
TB(umol/L) 12.88 ± 4.76
DB (umol/L) 2.35 ± 0.92
ALT 21.29 ± 12.79
AST 23.09 ± 7.38
GGT 25.72 ± 24.23
ALP 74.21 ± 18.04
Cr(umol/L) 64.90 ± 13.94
PT 12.85 ± 0.56
CEA 2.05 ± 1.00
intraoperative bleeding(%) 3(1.7%)
postoperative abdominal pain(%) 29(16.1%)
Postoperative fever(%) 16(8.9%)
Postoperative antibiotics(%) 126(70.0%)
Postoperative fasting time(h) 39.79(± 22.09)
Postoperative ICU(%) 1(0.6%)
postoperative bleeding(%) 2(1.1%)
postoperative hospital stay(day) 3.48 (± 1.61)
Hospital costs(Yuan) 19808.78 ± 5127.18
intraoperative perforation (%) 65(36.1%)
operation time(min) 60.56 ± 31.40